Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty-Reference-Cited by-同舟云学术

Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty

Published:1996-03 Issue:3 Volume:27 Page:536-542
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Kereiakes J.,Kleiman Neal S.,Ambrose John,Cohen Marc,Rodriguez Samuel,Palabrica Theresa,Herrmann Howard C.,Sutton Joseph M.,Weaver W.Douglas,McKee Donna B.,Fitzpatrick Virginia,Sax Frederic L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Acute coronary occlusion during and after percutaneous transminal coronary angioplasty: frequency, prediction, clinical course, management and follow up;de Feyter;Circulation,1991

2. Incidence and consequences of periprocedural occlusion: the 1985–1986 National Heart, Lung, and Blood Institute Percutaneous Coronary Angioplasty Registry;Detre;Circulation,1990

3. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile;Lincoff;J Am Coll Cardiol,1992

4. Platelet deposition at angioplasty site and platelet survival time after PTA in iliac and femoral arteries: Investigations with indium-111-oxide labeled platelets in patients with ASA (1.0 g/D) therapy;Minar;Thromb Haemost,1987

5. Influence of arterial wall damage and wall sheer rate on platelet deposition: ex vivostudy in a swine model;Badimon;Arteriosclerosis,1986

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ticagrelor washout bridged with GPIIb/IIIa inhibitor infusion to facilitate surgical care following placement of pipeline flow diverters: a case report;Journal of Neurocritical Care;2023-06-30

2. An Updated Review on Glycoprotein IIb/IIIa Inhibitors as Antiplatelet Agents: Basic and Clinical Perspectives;High Blood Pressure & Cardiovascular Prevention;2023-01-13

3. Myotoxin-3 from the Pacific Rattlesnake Crotalus oreganus oreganus Venom Is a New Microtubule-Targeting Agent;Molecules;2022-11-25

4. Tirofiban potentiates agonist-induced platelet activation and degranulation, despite effectively inhibiting aggregation;Platelets;2022-06-14

5. Antiplatelet Agents in Acute ST Elevation Myocardial Infarction;The American Journal of Medicine;2022-06